P0367: A Clustering approach to discriminate slow and rapid biologics switchers in difficult-to-treat Crohn’s Disease patients.ECCO'25Year: 2025
Authors: Vuckovic, C.(1)*;Cremer, A.(1);Minsart, C.(1);Amininejad, L.(1);Bottieau, J.(2);Franchimont, D.(1);Liefferinckx, C.(1);
(1)HUB-Erasme, Gastroenterology, Bruxelles, Belgium;(2)Université Libre de Bruxelles, Laboratoire de Gastro-Enterologie Expérimentale LGE, Bruxelles, Belgium;
P0368: Novel endoluminal parameters to predict primary loss of response in patients with Crohn’s disease: a national survey and multi-centre study.ECCO'25Year: 2025
Authors: Shen, J.(1);Feng, Q.(2);Yao, R.(1)*;Cai, C.(1);Liang, J.(3);Tian, F.(4);Cao, X.(5);Li, Y.(6);Gu, Y.(7);
(1)Renji Hospital- School of Medicine- Shanghai Jiao Tong University, Division of Gastroenterology and Hepatology, Shanghai, China;(2)Renji Hospital- School of Medicine- Shanghai Jiao Tong University, Department of Radiology- Renji Hospital- School of Medicine, Shanghai, China;(3)Xijing Hospital of Digestive Diseases- Fourth Military Medical University, 3. State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xian, China;(4)Shengjing Hospital of China Medical University, Department of Gastroenterology, Shenyang, China;(5)Tianjin Medical University General Hospital- Tianjin Medical University, Department of Gastroenterology and Hepatology, Tianjin, China;(6)Peking Union Medical College Hospital- Chinese Academy of Medical Sciences & Peking Union Medical College, Department of Gastroenterology, Beijing, China;(7)Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Department of Gastroenterology, Shanghai, China; Mimic Inflammatory Bowel Disease Research Group
[1] Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, Friedman JR, Blank MA, Johanns J, Gao LL, Miao Y, Adedokun OJ, Sands BE, Hanauer SB, Vermeire S, Targan S, Ghosh S, de Villiers WJ, Colombel JF, Tulassay Z, Seidler U, Salzberg BA, Desreumaux P, Lee SD, Loftus EV, Jr., Dieleman LA, Katz S, Rutgeerts P, Group U-I-US. Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease. N Engl J Med. 2016 Nov 17;375(20):1946-1960.
P0369: The use of exhaled volatile organic compounds for the non-invasive assessment of endoscopic inflammation in patients with ileal pouch anal anastomosis (IPAA)ECCO'25Year: 2025
Authors: Qazi, T.(1)*;Cohen, B.(2);Ma, J.(3);Yang, Q.(4);Grove, D.(3);Regueiro, M.(5);Dweik, R.(6);Rieder, F.(7);
(1)Cleveland Clinic Foundation, Digestive Disease and Surgery Institute, Beachwood, United States;(2)Cleveland Clinic Foundation, Digestive Disease and Surgery Institute, Cleveland, United States;(3)Lerner Research Institute, Department of Inflammation and Immunity, Cleveland, United States;(4)Lerner Research institute, Quantitative Health Sciences, Cleveland, United States;(5)Cleveland Clinic Foundation, Digestive Disease and Surgery, Cleveland, United States;(6)Cleveland Clinic Foundation: Respiratory Institute, Pulmonary Medicine, Cleveland, United States;(7)Cleveland Clinic Foundation- Lerner Research Institute, Digestive Disease and Surgery Institute- Department of Inflammation and Immunity, Cleveland, United States;
P0370: Transmural healing in Ulcerative Colitis patients improves long-term outcomes compared to endoscopic healing aloneECCO'25Year: 2025
Authors: Lim, C.T.(1,2)*;Teichert, C.(2);Pruijt, M.(2);de Voogd, F.(2);D'Haens, G.(2);Gecse, K.(2);
(1)Singapore General Hospital, Departent of Gastroenterology and Hepatology, Singapore, Singapore;(2)Amsterdam University Medical Centre, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;
1. Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160(5):1570-1583. doi:10.1053/j.gastro.2020.12.031
P0371: Building a Robust Artificial Intelligence Solution for Use in Ulcerative Colitis Clinical TrialsECCO'25Year: 2025
Authors: Byrne, M.(1,2)*;Requa, J.(2);Panés, J.(3);Bressler, B.(4);Panaccione, R.(5);Mendel, R.(2);East, J.E.(6);Parsa, N.(2,7);Banerjee, R.(8);Kalapala, R.(8);Reddy, D.N.(8);Rughwani, H.R.(8);Flegg, D.(9);Moran, G.(10);Gallinger, Z.(11);Cheung, V.(6);Tan, M.(12);Ma, C.(5);Travis, S.P.(6);Jairath, V.(13);
(1)Vancouver General Hospital - University of British Columbia, Division of Gastroenterology, Vancouver, Canada;(2)Satisfai Health, AI IBD Group, Vancouver, Canada;(3)Hospital Clinic de Barcelona, Division of Gastroenterology, Barcelona, Spain;(4)St. Paul's Hospital - University of British Columbia, Division of Gastroenterology, Vancouver, Canada;(5)University of Calgary, Division of Gastroenterology & Hepatology, Calgary, Canada;(6)University of Oxford, Translational Gastroenterology Unit and Oxford NIHR Biomedical Research Centre- Nuffield Department of Clinical Medicine- Experimental Medicine Division, Oxford, United Kingdom;(7)University of Minnesota, Division of Gastroenterology Hepatology & Nutrition, Minneapolis, United States;(8)Asian Institute of Gastroenterology, Division of Gastroenterology, Hyderabad, India;(9)University of British Columbia, Division of Internal Medicine, Vancouver, Canada;(10)University of Nottingham, Division of Gastroenterology, Nottingham, United Kingdom;(11)Sinai Health System, Division of Gastroenterology, Toronto, Canada;(12)Singapore General Hospital, Division of Gastroenterology & Hepatology, Singapore, Singapore;(13)Alimentiv, Clinical Trial Division, London, Canada;
P0372: Fatigue in Swedish patients with Inflammatory bowel diseaseECCO'25Year: 2025
Authors: Jäghult, S.(1)*;Pilhl Lesnovska, K.(2);Marsal, J.(3);
(1)Södersjukhuset, Karolinska Institutet, Stockholm, Sweden;(2)Linköpings Universitetssjukhus, Linköpings Universitetssjukhus, Linköping, Sweden;(3)Skåne Universitetssjukhus, Skåne Universitetssjukhus, Malmö, Sweden;
P0373: CLINICAL RECURRENCE AFTER ILEOCOLIC RESECTION FOR CROHN'S DISEASE: Interest of the REMIND group's endoscopic scoreECCO'25Year: 2025
Authors: Amal, J.(1)*;Abdelwahab, N.(1);Sonia, B.(1);myriam, A.(2);zeineb, B.(1);nessrine, H.(1);bochra, B.(1);taieb, J.(2);rym, E.(1);Med Hedi, D.(2);
(1)Mongi Slim Hospital, Gastroenterology, Tunis, Tunisia;(2)FSI Hospital, gastroenterology, tunis, Tunisia;
Hammoudi N, Auzolle C, Tran Minh ML, Boschetti G, Bezault M, Buisson A, et al. Postoperative endoscopic recurrence on the neoterminal ileum but not on the anastomosis is mainly driving long-term outcomes in crohn’s disease. Am J Gastroenterol. 2020 Jul;115(7):1084-93.
P0374: Prevalence, risk factors and clinical outcomes of malignancies in patients with Inflammatory Bowel Disease: a case-control studyECCO'25Year: 2025
Authors: Foteinogiannopoulou, K.(1)*;Nikolaou, P.(2);Orfanoudaki, E.(1);Theodoraki, E.(1);Theodoropoulou, A.(2);Karmiris, K.(2);Koutroubakis, I.(1);
(1)University Hospital of Heraklion, Department of Gastroenterology, Heraklion, Greece;(2)Venizelion General Hospital, Department of Gastroenterology, Heraklion, Greece;
1. Jess T, Simonsen J, Jørgensen KT, Pedersen BV, Nielsen NM, Frisch M. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology. 2012 Aug;143(2):375-81.e1; quiz e13-4.
2. Lutgens MW, van Oijen MG, van der Heijden GJ, Vleggaar FP, Siersema PD, Oldenburg B. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis. 2013; 19: 789–99.
P0375: Fibromyalgia as a predictive factor of fatigue and reduced quality of life in patients with inflammatory bowel disease.ECCO'25Year: 2025
Authors: Prado , R.D.C.P.(1);Domiciano , D.S.(2);Mattos , P.S.L.D.(1);Linhares , F.D.S.(1);Azevedo , M.F.C.D.(1);Carlos , A.D.S.(1);Damião , A.O.M.C.(1);Barros , L.L.(1)*;
(1)University of São Paulo School of Medicine, Department of Gastroenterology and Nutrology, São Paulo, Brazil;(2)University of São Paulo School of Medicine, Department of Rheumatology, São Paulo, Brazil;
1. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, Mease PJ, Russell AS, Russell IJ, Walitt B. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016 Dec;46(3):319-329.
2. Kocyigit BF, Akyol A. Fibromyalgia syndrome: epidemiology, diagnosis and treatment. Reumatologia. 2022;60(6):413-421.
3. Martinis F, Tinazzi I, Bertolini E, Citriniti G, Variola A, Geccherle A, Marchetta A, McGonagle D, Macchioni P. Clinical and sonographic discrimination between fibromyalgia and spondyloarthopathy in inflammatory bowel disease with musculoskeletal pain. Rheumatology (Oxford). 2020 Oct 1;59(10):2857-2863.
P0376: Advancing intestinal ultrasound for IBD in Turkey: results of a national survey.ECCO'25Year: 2025
Authors: Bilican, G.(1);Karakan, T.(1);Eğritaş Gürkan, Ö.(2);Sabhan, H.(3);Hedin, C.(4);Forss, A.(5);Petrousis, G.(6);Cindoruk, M.(1);Can, A.(2);Haas, S.L.(6,7)*;
(1)Gazi University, Faculty of Medicine- Department of Gastroenterology, Ankara, Turkey;(2)Gazi University, Faculty of Medicine- Department of Pediatric Gastroenterology, Ankara, Turkey;(3)Saint Göran Hospital and Karolinska Institutet, Department of Medicine- Solna, Stockholm, Sweden;(4)Karolinska University Hospital, Centre for Digestive Health- Department of Gastroenterology- Dermatovenereology and Rheumatology- Karolinska Institutet- Department of Medicine- Solna, Stockholm, Sweden;(5)Karolinska Institutet, Department of Medical Epidemiology and Biostatistics- Department of Medicine- Solna, Stockolm, Sweden;(6)Karolinska University Hospital, Centre for Digestive Health- Department of Gastroenterology- Dermatovenereology and Rheumatology, Stockholm, Sweden;(7)Karolinska Institutet, Department of Medicine- Huddinge, Stockholm, Sweden;
1Chavannes M, Dolinger MT, Cohen-Mekelburg S, Abraham B. AGA Clinical Practice Update on the Role of Intestinal Ultrasound in Inflammatory Bowel Disease: Commentary. Clin Gastroenterol Hepatol. 2024;22(9):1790-1795.e1. doi:10.1016/j.cgh.2024.04.039.
2Pruijt MJ, de Voogd FAE, Montazeri NSM, van Etten-Jamaludin FS, D'Haens GR, Gecse KB. Diagnostic accuracy of intestinal ultrasound in the detection of intra-abdominal complications in Crohn's disease: A systematic review and meta-analysis. J Crohns Colitis. 2024;18(6):958-972. doi:10.1093/ecco-jcc/jjad215
3Ivermark JFKF, Hansen T, Goodsall TM, Seidelin JB, Al-Farhan H, Allocca M, Begun J, Bryant RV, Carter D, Christensen B, Dubinsky MC, Gecse KB, Kucharzik T, Lu C, Maaser C, Maconi G, Nylund K, Palmela C, Wilson SR, Novak K, Wilkens R. Defining Transabdominal Intestinal Ultrasound Treatment Response and Remission in Inflammatory Bowel Disease: Systematic Review and Expert Consensus Statement. J Crohns Colitis. 2022;16(4):554-580. doi:10.1093/ecco-jcc/jjab173.
4Verstockt B, Stoker J, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13(2):144-164. doi:10.1093/ecco-jcc/jjy_154.
P0377: Development of Crohn's Aid mobile application based on AI algorithms to make an early diagnosis of Crohns Disease in TB endemic regionsECCO'25Year: 2025
Authors: Mohta, S.(1)*;Kutum, R.(2);Pendyala, R.(2);Dev, H.(2);Kante, B.(1);Kumar Vuyyuru, S.(1);Kumar, P.(1);Virmani, S.(1);Kumar, M.(1);Bahl, S.(1);Makharia, G.(1);Chaudhury, S.(3);Kedia, S.(1);Sethi, T.(2);Ahuja, V.(1);
(1)All India Institute of Medical Sciences, Department of Gastroenterology and Human Nutrition, New Delhi, India;(2)Indraprastha Institute of Information Technology, Department of Computational Biology, New Delhi, India;(3)Indian Institute of Technology, Department of Electrical Engneering, New Delhi, India;
P0379: Characteristics of histologically confirmed upper gastrointestinal lesions in patients with Crohn's disease in KoreaECCO'25Year: 2025
Authors: Na, S.Y.(1)*;Ji, J.S.(1);Choi, H.(1);
(1)Incheon St. Mary's Hospital- The Catholic University of Korea, Internal Medicine, Incheon, Korea- Republic Of;
1. So H, Ye BD, Park YS, et al. Gastric lesions in patients with Crohn's disease in Korea: a multicenter study. Intest Res 2016;14:60-8.
2. Graca-Pakulska K, Błogowski W, Zawada I, et al. Endoscopic findings in the upper gastrointestinal tract in patients with Crohn's disease are common, highly specific, and associated with chronic gastritis. Sci Rep 2023 13;13:703.
3. Greuter T, Piller A, Nicolas Fournier N, et al. Upper Gastrointestinal Tract Involvement in Crohn's Disease: Frequency, Risk Factors, and Disease Course. J Crohns Colitis 2018;12:1399-1409.
P0380: Mild Hyperemia in the Absence of Bowel Wall Thickening on Intestinal Ultrasound is Associated with Biochemical Disease Activity and Worse Disease Outcomes in Patients with Crohn’s Disease and Ulcerative ColitisECCO'25Year: 2025
Authors: Krugliak Cleveland, N.(1)*;Bhondwe, K.(2);Duty, C.(1);Fear, E.(1);George, T.(1);Ayoub, Q.N.(3);McDonald, B.(3);Kellar, A.(1);Rubin, D.(1);
(1)University of Chicago Medical Center, Inflammatory Bowel Disease Center, Chicago, United States;(2)University of Chicago Medical Center, Inflammatory Bowel Diseases Center, Chicago, United States;(3)University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, United States;
P0381: Correlation Between Rectal Endoscopic and Histological Involvement and the Prevalence and Severity of Ano-Perineal Lesions in Inflammatory Bowel DiseaseECCO'25Year: 2025
Authors: Elommal, H.(1)*;Koulali, H.(2);Elmqaddem, O.(2);Zazour, A.(1);ismaili, Z.(2);Kharrasse, G.(2);
(1)Service d’Hépato-gastro-entérologie CHU MOHAMMED VI Oujda- Université Mohammed Premier Oujda- Laboratoire de recherche de maladie de l’appareil digestif LARMAD.MAROC, Service d’Hépato-gastro-entérologie CHU MOHAMMED VI Oujda, Oujda, Morocco;(2)Service d’Hépato-gastro-entérologie CHU MOHAMMED VI Oujda- Université Mohammed Premier Oujda- Laboratoire de recherche de maladie de l’appareil digestif LARMAD.MAROC, Service d’Hépato-gastro-entérologie CHU MOHAMMED VI Oujda- Université Mohammed Premier Oujda, Oujda, Morocco;
P0382: Identifying atypical disease phenotypes in paediatric Ulcerative Colitis: Insights from the real world PIBD-SETQuality cohortECCO'25Year: 2025
Authors: Camman, A.(1)*;Klomberg, R.(1);Peters, P.(1);Christos, T.(2);Koletzko, S.(3);Russell, R.(4);Nedelkopoulou, N.(5);Croft*, N.(6);de Ridder*, L.(1);
(1)Erasmus University Medical Center - Sophia Children's Hospital, Department of Paediatric Gastroenterology, Rotterdam, The Netherlands;(2)Al Jalila Children's Hospital, Department of Paediatric Gastroenterology, Dubai, United Arab Emirates;(3)Dr von Haunersches Kinderspital - Ludwig-Maximilians-University, Division of Paediatric Gastroenterology and Hepatology, Munich, Germany;(4)Royal Hospital for Children, Department of Paediatric Gastroenterology, Glasgow, United Kingdom;(5)Sheffield Children's Hospital NHS Foundation Trust, Paediatric Gastroenterology Department, Sheffield, United Kingdom;(6)Queen Mary University of London- Barts and the London School of Medicine, Paediatric Gastroenterology, London, United Kingdom;
1. Birimberg-Schwartz L, Zucker DM, Akriv A, et al. Pediatric IBD Porto Group of ESPGHAN. Development and validation of diagnostic criteria for IBD subtypes including IBD-unclassified in children: a multicentre study from the Pediatric IBD Porto Group of ESPGHAN. J Crohns Colitis. 2017;11(9):1078-1084. doi:10.1093/ecco-jcc/jjx053.
P0383: Factors associated with steatotic liver disease associated with metabolic dysfunction (MASLD) in patients with Inflammatory Bowel Disease (IBD)ECCO'25Year: 2025
Authors: Oliveira, E.C.S.D.(1)*;Lopes , M.A.(1);Beraldo, R.F.(1);Castelhano , N.S.(1);Baima, J.P.(1);Herrerias, G.S.P.(1);Quaglio, A.E.V.(2);Di Stasi, L.C.(3);Barbosa , W.F.(1);Silva, G.F.(1);Sassaki, L.Y.(1);
(1)São Paulo State University Unesp- Medical School, Department of Internal Medicine, Botucatu, Brazil;(2)Verum Ingredients, Botucatu Technology Park, Botucatu, Brazil;(3)São Paulo State University Unesp- Institute of Biosciences, Department of Biophysics and Pharmacology, Botucatu, Brazil;
P0384: Applying ChatGPT to Improve Inflammatory Bowel Disease Diagnosis and EvaluationECCO'25Year: 2025
Authors: Ozturk, O.(1)*;Coskun, O.(1);Yavuz, C.(1);Tenlik, I.(1);Yuksel, I.(1,2);
(1)Ankara Bilkent City Hospital, Gastroenterology, Ankara, Turkey;(2)Ankara Yildirim Beyazit University- School of Medicine, Gastroenterology, Ankara, Turkey;
P0385: Delayed Diagnosis in Inflammatory Bowel Disease in Turkish PopulationECCO'25Year: 2025
Authors: Acehan, M.F.(1);Yilmaz, V.(1);Koç, Ö.(1)*;Güvenir, S.T.(1);Er, R.E.(1);Soykan, A.İ.(1);Toruner, M.(2);
(1)Ankara university school of medicine, Department of gastroenterology, Ankara, Turkey;(2)Ankara University Medical School- Ibni-sina Hospital, Department of Gastroenterology, Ankara, Turkey;
P0386: Prevalence and Impact of Anorectal Disorders in IBD: Insights from a Romanian Tertiary Gastroenterology CenterECCO'25Year: 2025
Authors: Costache, R.E.(1)*;Dimitriu, A.(1,2);Marinescu, A.(2);Saizu, I.A.(2);Gheorghe, L.(1,2);Gheorghe, C.(1,2);
(1)University of Medicine and Pharmacy "Carol Davila", Gastroenterology and Hepatology, Bucharest, Romania;(2)Clinical Institute Fundeni- Center of Digestive Disease and Liver Transplantation, Gastroenterology and Hepatology, Bucharest, Romania;
Norton, Christine et al. "Faecal incontinence in inflammatory bowel disease: associations and effect on quality of life." Journal of Crohn's & colitis vol. 7,8 (2013): e302-11. doi:10.1016/j.crohns.2012.11.004
Dibley, Lesley et al. "Development and initial validation of a disease-specific bowel continence questionnaire for inflammatory bowel disease patients: the ICIQ-IBD." European journal of gastroenterology & hepatology vol. 28,2 (2016): 233-9. doi:10.1097/MEG.0000000000000513
